2-Oxo-2H-chromene-3-carboxylic Acid [3-(4-Hydroxyphenyl)-propyl]amide

ID: ALA4092206

PubChem CID: 110667198

Max Phase: Preclinical

Molecular Formula: C19H17NO4

Molecular Weight: 323.35

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(NCCCc1ccc(O)cc1)c1cc2ccccc2oc1=O

Standard InChI:  InChI=1S/C19H17NO4/c21-15-9-7-13(8-10-15)4-3-11-20-18(22)16-12-14-5-1-2-6-17(14)24-19(16)23/h1-2,5-10,12,21H,3-4,11H2,(H,20,22)

Standard InChI Key:  YSSVZZNDRWDQQF-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 24 26  0  0  0  0  0  0  0  0999 V2000
   14.2664  -13.1328    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.2653  -13.9523    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.9733  -14.3613    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.9715  -12.7239    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.6801  -13.1292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.6790  -13.9544    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3891  -14.3657    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.1049  -13.9564    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.1061  -13.1313    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3914  -12.7154    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.8114  -14.3670    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.8148  -12.7244    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.5215  -13.1347    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.8168  -11.9072    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.2302  -12.7279    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.9369  -13.1382    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.6456  -12.7313    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.3523  -13.1416    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.3454  -13.9593    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.0513  -14.3696    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.7610  -13.9627    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.7603  -13.1412    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.0539  -12.7347    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.4682  -14.3721    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  5 10  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
  8 11  2  0
  9 12  1  0
 12 13  1  0
 12 14  2  0
 13 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 18  1  0
 21 24  1  0
M  END

Associated Targets(Human)

AKR1B10 Tchem Aldo-keto reductase family 1 member B10 (300 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AKR1B1 Tclin Aldose reductase (1404 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 323.35Molecular Weight (Monoisotopic): 323.1158AlogP: 2.86#Rotatable Bonds: 5
Polar Surface Area: 79.54Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 9.51CX Basic pKa: CX LogP: 2.94CX LogD: 2.94
Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.56Np Likeness Score: -0.48

References

1. Endo S, Xia S, Suyama M, Morikawa Y, Oguri H, Hu D, Ao Y, Takahara S, Horino Y, Hayakawa Y, Watanabe Y, Gouda H, Hara A, Kuwata K, Toyooka N, Matsunaga T, Ikari A..  (2017)  Synthesis of Potent and Selective Inhibitors of Aldo-Keto Reductase 1B10 and Their Efficacy against Proliferation, Metastasis, and Cisplatin Resistance of Lung Cancer Cells.,  60  (20): [PMID:28976752] [10.1021/acs.jmedchem.7b00830]

Source